Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2008-01-09 (18 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MARSEILLE (13006), Bouches-du-Rhone
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DU COURS JULIEN : revenue, balance sheet and financial ratios
PHARMACIE DU COURS JULIEN is a French company
founded 18 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MARSEILLE (13006),
this company of category PME
shows in 2015 a revenue of 420 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU COURS JULIEN (SIREN 501849913)
Indicator
2015
Revenue
419 872 €
Net income
1 083 €
EBITDA
375 €
Net margin
0.3%
Revenue and income statement
In 2015, PHARMACIE DU COURS JULIEN achieves revenue of 420 k€. After deducting consumption (308 k€), gross margin stands at 112 k€, i.e. a rate of 27%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 375 €, representing 0.1% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 1 k€, i.e. 0.3% of revenue. This profit can be retained or distributed to shareholders.
Revenue (2015)
?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production
419 872 €
Gross margin (2015)
?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed
112 353 €
EBITDA (2015)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
375 €
EBIT (2015)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
5 082 €
Net income (2015)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
1 083 €
EBITDA margin (2015)
?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability 5-10% : Average < 5% : Low
0.1%
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 138%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 36%. The balance between equity and debt is satisfactory.
Debt ratio (2015)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
137.87%
Financial autonomy (2015)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
35.963%
Cash flow / Revenue (2015)
?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates
-0.863%
Repayment capacity (2015)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
-55.221
Asset age ratio (2015)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DU COURS JULIEN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
Debt ratio
137.87
Financial autonomy
35.963
Repayment capacity
-55.221
Cash flow / Revenue
-0.863%
Sector positioning
Debt ratio
137.872015
2015
Q1: 49.3
Med: 174.5
Q3: 447.53
Good
In 2015, the debt ratio of PHARMACIE DU COURS JULIEN (137.87) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
35.96%2015
2015
Q1: 12.22%
Med: 24.83%
Q3: 41.67%
Good
In 2015, the financial autonomy of PHARMACIE DU COURS JULIEN (36.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
-55.22 years2015
2015
Q1: 2.13 years
Med: 6.76 years
Q3: 11.7 years
Excellent
In 2015, the repayment capacity of PHARMACIE DU COURS JULIEN (-55.22) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 190.44. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 981.9x. Operating income very largely covers interest expenses: high safety margin.
Liquidity ratio (2015)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
190.436
Interest coverage (2015)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
981.867
Liquidity indicators evolution PHARMACIE DU COURS JULIEN
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
Liquidity ratio
190.436
Interest coverage
981.867
Sector positioning
Liquidity ratio
190.442015
2015
Q1: 104.04
Med: 143.91
Q3: 202.52
Good
In 2015, the liquidity ratio of PHARMACIE DU COURS JULIEN (190.44) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
981.87x2015
2015
Q1: 6.08x
Med: 13.88x
Q3: 23.76x
Excellent
In 2015, the interest coverage of PHARMACIE DU COURS JULIEN (981.9x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 46 days. Excellent situation: suppliers finance 46 days of the operating cycle (retail model). Inventory turnover is 43 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 35 days of revenue, i.e. 40 k€ to permanently finance.
Operating WCR (2015)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
40 249 €
Customer credit (2015)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2015)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
46 j
Inventory turnover (2015)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
43 j
WCR in days of revenue (2015)
?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management
35 j
WCR and payment terms evolution PHARMACIE DU COURS JULIEN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
Operating WCR
40 249 €
Inventory turnover (days)
43
Customer payment term (days)
0
Supplier payment term (days)
46
Positioning of PHARMACIE DU COURS JULIEN in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 1804 transactions of similar company sales
(all years),
the value of PHARMACIE DU COURS JULIEN is estimated at
95 448 €
(range 72 220€ - 113 849€).
With an EBITDA of 375€, the sector multiple of 8.9x is applied.
The price/revenue ratio is 0.72x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2015
1804 transactions
72k€95k€113k€
95 448 €Range: 72 220€ - 113 849€
NAF 5 all-time
Valuation detail by method
Ajustez les pondérations selon votre analyse
EBITDA Multiple50%
375 €×8.9x
Estimation3 337 €
2 389€ - 4 994€
Revenue Multiple30%
419 872 €×0.72x
Estimation303 357 €
230 783€ - 357 406€
Net Income Multiple20%
1 083 €×12.8x
Estimation13 863 €
8 955€ - 20 651€
How is this estimate calculated?
This estimate is based on the analysis of 1804 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU COURS JULIEN with other companies in the same sector:
Frequently asked questions about PHARMACIE DU COURS JULIEN
What is the revenue of PHARMACIE DU COURS JULIEN ?
The revenue of PHARMACIE DU COURS JULIEN in 2015 is 420 k€.
Is PHARMACIE DU COURS JULIEN profitable?
Yes, PHARMACIE DU COURS JULIEN generated a net profit of 1 k€ in 2015.
Where is the headquarters of PHARMACIE DU COURS JULIEN ?
The headquarters of PHARMACIE DU COURS JULIEN is located in MARSEILLE (13006), in the department Bouches-du-Rhone.
Where to find the tax return of PHARMACIE DU COURS JULIEN ?
The tax return of PHARMACIE DU COURS JULIEN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU COURS JULIEN operate?
PHARMACIE DU COURS JULIEN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart